We are live on
!
Find out more
DCM
Driehaus Capital Management Portfolio holdings
AUM
$13.6B
1-Year Est. Return
173.98%
This Fund
S&P 500
This Quarter
Est. Return
+16.2%
1 Year Est. Return
+173.98%
3 Year Est. Return
+706.72%
5 Year Est. Return
+1,585.86%
10 Year Est. Return
+31,592.09%
AUM
$6.6B
AUM Growth
+$430M
(+7%)
Cap. Flow
+$25.1M
Cap. Flow
% of AUM
0.38%
Top 10 Holdings %
Top 10 Hldgs %
17.96%
Holding
434
New
82
Increased
115
Reduced
129
Closed
91
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Calix
CALX
|
+$48.2M |
| 2 |
AXNX
Axonics, Inc. Common Stock
AXNX
|
+$44.8M |
| 3 |
Wingstop
WING
|
+$42.6M |
| 4 |
EPAM Systems
EPAM
|
+$40M |
| 5 |
RB Global
RBA
|
+$38.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$75.3M |
| 2 |
FIVE9
FIVN
|
+$40.4M |
| 3 |
AAR Corp
AIR
|
+$34.3M |
| 4 |
DigitalOcean
DOCN
|
+$32.2M |
| 5 |
XPeng
XPEV
|
+$30.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.47% |
| 2 | Technology | 20.32% |
| 3 | Industrials | 15.76% |
| 4 | Consumer Discretionary | 10.97% |
| 5 | Consumer Staples | 8.2% |
Similar funds
CC
PMAM
SA
PSCM
WHG
AA
WA
SAM
Driehaus Capital Management's Q3 2022 Portfolio in Review
As of Q3 2022, Driehaus Capital Management held 434 positions worth $6.6B, up 7% from $6.17B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Driehaus Capital Management's Q3 2022 filing shows 82 new, 115 increased, 129 reduced and 91 closed positions. Its largest new stake was Axonics, Inc. Common Stock: 648,976 shares worth $45.7M. The largest sale was Pfizer, an estimated $75.3M.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 23% a quarter earlier, followed by Technology and Industrials.
- Driehaus Capital Management's largest Q3 2022 buy was Axonics, Inc. Common Stock: 648,976 shares worth $45.7M.
- Driehaus Capital Management added most to Calix in Q3 2022, an estimated $48.2M increase.
- Driehaus Capital Management's biggest Q3 2022 reduction was HDFC Bank, cutting an estimated $30M.
- Driehaus Capital Management fully exited Pfizer in Q3 2022, selling an estimated $75.3M.
- Driehaus Capital Management's ten largest holdings make up 18% of its $6.6B portfolio in Q3 2022.
- Driehaus Capital Management opened 82 new positions and closed 91 in Q3 2022.
- Driehaus Capital Management's portfolio value rose 7% quarter-over-quarter to $6.6B.
Based on Driehaus Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.